close
close
migores1

AstraZeneca to pay up to $2 billion to license cardiovascular drugs

Photo of Vaseline VaselineOctober 7, 2024
0 Less than a minute
AstraZeneca to pay up to billion to license cardiovascular drugs

AstraZeneca to pay up to billion to license cardiovascular drugs

AstraZeneca announced Monday it will pay up to $2 billion to license a cardiovascular drug.

Photo of Vaseline VaselineOctober 7, 2024
0 Less than a minute
Photo of Vaseline

Vaseline

Related Articles

Union Pacific Co. Stock (NYSE:UNP) sold by Holistic Financial Partners

Union Pacific Co. Stock (NYSE:UNP) sold by Holistic Financial Partners

September 1, 2024
Capstone Triton Financial Group LLC increases its position in iShares Core S&P 500 ETF (NYSEARCA:IVV)

Capstone Triton Financial Group LLC increases its position in iShares Core S&P 500 ETF (NYSEARCA:IVV)

September 22, 2024
Atria Wealth Solutions Inc. buys 8,822 shares of FT Vest US Equity Buffer ETF – May (BATS:FMAY)

Atria Wealth Solutions Inc. buys 8,822 shares of FT Vest US Equity Buffer ETF – May (BATS:FMAY)

August 25, 2024
USD/JPY trades slight losses near 147.00 ahead of US PPI data

USD/JPY trades slight losses near 147.00 ahead of US PPI data

August 13, 2024
Back to top button